SXR1096

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
160	先天性魚鱗癬	3

160. 先天性魚鱗癬

臨床試験数 : 42 / 薬物数 : 71 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 112

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-003210-39-AT (EUCTR)	01/02/2022	08/09/2021	A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled study to eval ...	A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled, first-time-i ...	Netherton syndrome MedDRA version: 20.0;Level: PT;Classification code 10062909;Term: Netherton's syn ...	Product Code: SXR1096 INN or Proposed INN: SXR1096 Other descriptive name: SXR1096	Sixera Pharma	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 1;Phase 2	Finland;Austria
2	EUCTR2021-003210-39-FI (EUCTR)	23/11/2021	20/08/2021	A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled study to eval ...	A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled, first-time-i ...	Netherton-syndrome MedDRA version: 20.0;Level: PT;Classification code 10062909;Term: Netherton's syn ...	Product Code: SXR1096	Sixera Pharma	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 1;Phase 2	Finland
3	EUCTR2021-003210-39-DE (EUCTR)		25/02/2022	A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled study to eval ...	A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled, first-in-hum ...	Netherton syndrome MedDRA version: 20.0;Level: PT;Classification code 10062909;Term: Netherton's syn ...	Product Code: SXR1096 INN or Proposed INN: SXR1096 Other descriptive name: SXR1096	Sixera Pharma	NULL	NA			Female: yes Male: yes	20	Phase 1;Phase 2	Finland;Austria;Germany

First Previous1Next Last